What changes for GLP-1 costs on January 1, 2027
Only changes an official source has published: CMS and Medicare.gov, the makers' self-pay listings on TrumpRx.gov, and FDA. Grouped by how you pay. Checked Nov 14, 2026.
Short answer
On January 1, 2027, Medicare's negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) takes effect at $274 for a 30-day supply, and the Part D yearly out-of-pocket limit rises to $2,400. For self-pay, Novo Nordisk's $199 new-patient price and Foundayo's temporary low-dose prices end on December 31, 2026. Medicare's $50 GLP-1 Bridge continues through 2027.1514168
Source: CMS, Medicare.gov, TrumpRx.gov · checked Nov 14, 2026
Get your dates as a calendar file
If you have Medicare
- Semaglutide negotiated price, from Jan 1, 2027: $274 for a 30-day supply of Ozempic, Rybelsus or Wegovy (CMS lists $276.78 for one Ozempic 4 mg/3 mL pen and $385.63 for four Wegovy 2.4 mg pens).142 It is the price the drug company must make available to pharmacies for people with Part D, not what you pay; your share depends on your plan.3
- Part D yearly out-of-pocket limit: $2,400 in 2027, up from $2,100 in 2026.57 The standard deductible is $700 ($615 in 2026).6
- Medicare GLP-1 Bridge continues: CMS extended it through December 31, 2027.8 It covers Foundayo, Wegovy (injection or tablet) and the Zepbound KwikPen at $50 for a one-month supply,11 and its prior authorization stays valid through December 31, 2027 unless you change GLP-1s.9 The $50 does not count toward the Part D out-of-pocket limit.10
- BALANCE model: CMS delayed the Medicare Part D part of the BALANCE model for 2027.12
- Before then: Medicare Open Enrollment ends December 7, 2026; a drug plan you join or switch to by then starts January 1.13 Medicare GLP-1 coverage
If you pay yourself (self-pay)
- Wegovy and Ozempic injections: the $199 new-patient price for the first 2 fills covers fills through Dec 31, 2026.1415 From January 1, 2027 new patients pay the regular price ($349 a month for Wegovy at the starting strengths). Wegovy prices · Ozempic prices
- Foundayo: 2.5 mg is $149 through Dec 31, 2026, then $199; 5.5 mg is $199 through Dec 31, 2026, then $299.16 Foundayo prices
- No other dated change appears in the self-pay listings we track. Zepbound and Mounjaro prices have no end date in their listings.
If you take Saxenda
- FDA's drug shortage list says Saxenda "will be available until discontinuation in January 2027".17 Generic liraglutide 3 mg is listed by other makers. Liraglutide prices and makers
If you have commercial insurance or Medicaid
- Commercial plans set their own 2027 drug lists; there is no single official date for all plans. Check your plan's 2027 formulary. Commercial insurance and GLP-1s
- Medicaid coverage is set by each state. What each state's Medicaid covers, from the state's own documents.
Not on this page: changes reported only in the news (for example new list prices or savings-card end dates) until the official wording is published and we can cite it.
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Official sources for this page (17)
“Ozempic; Rybelsus; Wegovy Novo Nordisk Inc. Type 2 diabetes; Type 2 diabetes and cardiovascular disease; Cardiovascular disease and obesity/ overweight $274 $959 71%”
“These negotiated prices will become effective on January 1, 2027.”
“A participating drug company with a selected drug is required to ensure the negotiated price is made available to eligible individuals and to the pharmacies, mail-order services, and other entities that dispense the selected drug with respect to such individuals.”
“00169-4130-13 4 mg/3 mL Pen, 1 Pen (Ozempic) $276.78 00169-4307-30 7 mg, 30 Tablets (Rybelsus) $276.78 00169-4524-14 2.4 mg /0.75 mL Pen, 4 Pens (Wegovy) $385.63”
“Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
CMS: CY 2027 Medicare Advantage and Part D Rate Announcement (Table V-6) · as of Oct 23, 2026“Deductible: $615 Deductible: $700”
CMS: CY 2027 Medicare Advantage and Part D Rate Announcement (Table V-6) · as of Oct 23, 2026“Out-of-pocket limit Yearly $2,100 (in 2026).”
Medicare.gov: Medicare costs · as of Oct 23, 2026“The Centers for Medicare & Medicaid Services (CMS) is extending the Medicare GLP-1 Bridge through December 31, 2027.”
CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026“Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s.”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“Doesn’t count towards your yearly Medicare drug plan deductible or out-of-pocket limit and won’t appear on your Part D Explanation of Benefits (EOB).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“CMS will delay implementation of the Medicare Part D portion of Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Model for Calendar Year (CY) 2027 pending further evaluation and data collection.”
CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026“Open Enrollment Period October 15-December 7 … January 1 of the next year (the plan must get your request to join by December 7)”
Medicare.gov: Joining a plan (enrollment periods) · as of Nov 14, 2026“Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. Only available for 2 monthly fills between 11/17/2025- 12/31/2026. For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg.”
TrumpRx.gov: Wegovy Prefilled pen (injection) listing · as of Oct 17, 2026“Limited Time Offer – New self-pay patients pay $199* for the first two monthly fills of Ozempic® (semaglutide) injection 0.25mg or 0.5mg. Only available for 2 monthly fills between 11/17/2025 – 12/31/2026. For each fill after, pay $349/month for Ozempic® 0.25mg, 0.5mg or 1mg, and $499/month for Ozempic® 2mg. For eligible patients only.”
TrumpRx.gov: Ozempic Prefilled pen (injection) listing · as of Oct 17, 2026“The price for the 2.5mg dose is temporarily reduced through December 31, 2026. Regular price is $199. The price for the 5.5mg dose is temporarily reduced through December 31, 2026. Regular price is $299. *Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Foundayo Tablet listing · as of Oct 17, 2026“Product will be available until discontinuation in January 2027”